The effect of motesanib treatment on the gallbladder: A randomized phase Ib study in patients (pts) with advanced solid tumors.
N. C. Tebbutt(Austin Health), Lee S. Rosen(APLA Health), Lori J. Wirth(Massachusetts General Hospital), T.J. Price, Neil D. Belman(Lehigh Valley Hospital-Pocono), Joseph Stephenson, Y. Hei, Ralph V. Boccia(Center for Cancer and Blood Disorders), H. Hurwitz, R Sikorski(Johns Hopkins Medicine), Lara Lipton(The Royal Melbourne Hospital)
Cited by 3
Related Papers
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
|Genetics|1989|8.8k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|Breast Cancer Research and Treatment|2017|761
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
|Journal of Clinical Oncology|2017|653